Mylan Asks High Court If ANDA Subjects Filers To Specific Personal Jurisdiction
WASHINGTON, D.C. — Mylan Pharmaceuticals Inc. and Mylan Inc. (collectively, Mylan) ask the U.S. Supreme Court in a Sept. 19 petition whether the filing of an abbreviated new drug application (ANDA)...To view the full article, register now.
Already a subscriber? Click here to view full article